Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Burden of hydrocoele assessed from medical and surgical records in a lymphatic filariasis endemic country, Samoa.

Ah Leong-Lui TA, Graves PM, Naseri T.

Trop Med Health. 2019 Nov 6;47:51. doi: 10.1186/s41182-019-0179-0. eCollection 2019.

2.

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

Milligan R, Daher A, Graves PM.

Cochrane Database Syst Rev. 2019 Jul 5;7:CD012656. doi: 10.1002/14651858.CD012656.pub2.

3.

Elimination of lymphatic filariasis as a public health problem in Niue under PacELF, 1999-2016.

Carlingford CN, Melrose W, Mokoia G, Graves PM, Ichimori K, Capuano C, Kim SH, Aratchige P, Nosa M.

Trop Med Health. 2019 Mar 15;47:20. doi: 10.1186/s41182-019-0141-1. eCollection 2019.

4.

GEOFIL: A spatially-explicit agent-based modelling framework for predicting the long-term transmission dynamics of lymphatic filariasis in American Samoa.

Xu Z, Graves PM, Lau CL, Clements A, Geard N, Glass K.

Epidemics. 2019 Jun;27:19-27. doi: 10.1016/j.epidem.2018.12.003. Epub 2018 Dec 29.

5.

Combining different diagnostic studies of lymphatic filariasis for risk mapping in Papua New Guinea: a predictive model from microfilaraemia and antigenaemia prevalence surveys.

Berg Soto A, Xu Z, Wood P, Sanuku N, Robinson LJ, King CL, Tisch D, Susapu M, Graves PM.

Trop Med Health. 2018 Dec 4;46:41. doi: 10.1186/s41182-018-0123-8. eCollection 2018.

6.

The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar.

Dickson BFR, Graves PM, Aye NN, Nwe TW, Wai T, Win SS, Shwe M, Douglass J, Bradbury RS, McBride WJ.

PLoS Negl Trop Dis. 2018 Nov 12;12(11):e0006944. doi: 10.1371/journal.pntd.0006944. eCollection 2018 Nov.

7.

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.

Sheel M, Sheridan S, Gass K, Won K, Fuimaono S, Kirk M, Gonzales A, Hedtke SM, Graves PM, Lau CL.

PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006583. doi: 10.1371/journal.pntd.0006583. eCollection 2018 Jul.

8.

The extensive networks of frequent population mobility in the Samoan Islands and their implications for infectious disease transmission.

Xu Z, Lau CL, Zhou X, Fuimaono S, Soares Magalhães RJ, Graves PM.

Sci Rep. 2018 Jun 28;8(1):10136. doi: 10.1038/s41598-018-28081-x.

9.

Expanding the Vector Control Toolbox for Malaria Elimination: A Systematic Review of the Evidence.

Williams YA, Tusting LS, Hocini S, Graves PM, Killeen GF, Kleinschmidt I, Okumu FO, Feachem RGA, Tatarsky A, Gosling RD.

Adv Parasitol. 2018;99:345-379. doi: 10.1016/bs.apar.2018.01.003. Epub 2018 Feb 27.

PMID:
29530309
10.

Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.

Graves PM, Choi L, Gelband H, Garner P.

Cochrane Database Syst Rev. 2018 Feb 2;2:CD008152. doi: 10.1002/14651858.CD008152.pub5. Review.

11.

Overview of PacELF-the Pacific Programme for the Elimination of Lymphatic Filariasis.

Ichimori K, Graves PM.

Trop Med Health. 2017 Nov 1;45:34. doi: 10.1186/s41182-017-0075-4. eCollection 2017. No abstract available.

12.

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.

Lau CL, Sheridan S, Ryan S, Roineau M, Andreosso A, Fuimaono S, Tufa J, Graves PM.

PLoS Negl Trop Dis. 2017 Sep 18;11(9):e0005914. doi: 10.1371/journal.pntd.0005914. eCollection 2017 Sep.

13.

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies.

Uthman OA, Graves PM, Saunders R, Gelband H, Richardson M, Garner P.

Malar J. 2017 Aug 22;16(1):346. doi: 10.1186/s12936-017-1989-3. Review.

14.

Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration.

Coutts SP, King JD, Pa'au M, Fuimaono S, Roth J, King MR, Lammie PJ, Lau CL, Graves PM.

Trop Med Health. 2017 Aug 4;45:22. doi: 10.1186/s41182-017-0063-8. eCollection 2017.

15.

Lymphatic Filariasis in Mainland Southeast Asia: A Systematic Review and Meta-Analysis of Prevalence and Disease Burden.

Dickson BFR, Graves PM, McBride WJ.

Trop Med Infect Dis. 2017 Jul 27;2(3). pii: E32. doi: 10.3390/tropicalmed2030032. Review.

16.

Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu.

Taleo F, Taleo G, Graves PM, Wood P, Kim SH, Ozaki M, Joseph H, Chu B, Pavluck A, Yajima A, Melrose W, Ichimori K, Capuano C.

Trop Med Health. 2017 Jun 16;45:18. doi: 10.1186/s41182-017-0057-6. eCollection 2017.

17.

Identification and control of an isolated, but intense focus of lymphatic filariasis on Satawal Island, Federated States of Micronesia, in 2003.

Pretrick M, Melrose W, Chaine JP, Canyon D, Carron J, Graves PM, Bradbury RS.

Trop Med Health. 2017 Jun 9;45:17. doi: 10.1186/s41182-017-0050-0. eCollection 2017.

18.

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997-2006.

Allen T, Taleo F, Graves PM, Wood P, Taleo G, Baker MC, Bradley M, Ichimori K.

Trop Med Health. 2017 Jun 1;45:8. doi: 10.1186/s41182-017-0047-8. eCollection 2017.

19.

Relative Performance and Predictive Values of Plasma and Dried Blood Spots with Filter Paper Sampling Techniques and Dilutions of the Lymphatic Filariasis Og4C3 Antigen ELISA for Samples from Myanmar.

Masson J, Douglass J, Roineau M, Aye KS, Htwe KM, Warner J, Graves PM.

Trop Med Infect Dis. 2017 Apr 11;2(2). pii: E7. doi: 10.3390/tropicalmed2020007.

20.

Concordance between Plasma and Filter Paper Sampling Techniques for the Lymphatic Filariasis Bm14 Antibody ELISA.

Masson J, Douglass J, Roineau M, Aye KS, Htwe KM, Warner J, Graves PM.

Trop Med Infect Dis. 2017 Apr 7;2(2). pii: E6. doi: 10.3390/tropicalmed2020006.

21.

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame.

Lau CL, Won KY, Lammie PJ, Graves PM.

PLoS Negl Trop Dis. 2016 Nov 1;10(11):e0005108. doi: 10.1371/journal.pntd.0005108. eCollection 2016 Nov.

22.

Determinants of Bed Net Use in Southeast Nigeria following Mass Distribution of LLINs: Implications for Social Behavior Change Interventions.

Russell CL, Sallau A, Emukah E, Graves PM, Noland GS, Ngondi JM, Ozaki M, Nwankwo L, Miri E, McFarland DA, Richards FO, Patterson AE.

PLoS One. 2015 Oct 2;10(10):e0139447. doi: 10.1371/journal.pone.0139447. eCollection 2015.

23.

Evaluation of traps and lures for mosquito vectors and xenomonitoring of Wuchereria bancrofti infection in a high prevalence Samoan Village.

Hapairai LK, Plichart C, Naseri T, Silva U, Tesimale L, Pemita P, Bossin HC, Burkot TR, Ritchie SA, Graves PM, Melrose W, Joseph H.

Parasit Vectors. 2015 May 28;8:287. doi: 10.1186/s13071-015-0886-2.

24.

Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.

Graves PM, Gelband H, Garner P.

Cochrane Database Syst Rev. 2015 Feb 19;(2):CD008152. doi: 10.1002/14651858.CD008152.pub4. Review. Update in: Cochrane Database Syst Rev. 2018 Feb 02;2:CD008152.

25.

Seroepidemiology of melioidosis in children from a remote region of Papua New Guinea.

Diefenbach-Elstob TR, Graves PM, Burgess GW, Pelowa DB, Warner JM.

Int Health. 2015 Sep;7(5):332-8. doi: 10.1093/inthealth/ihu088. Epub 2014 Dec 8.

PMID:
25487725
26.

Seroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administration.

Lau CL, Won KY, Becker L, Soares Magalhaes RJ, Fuimaono S, Melrose W, Lammie PJ, Graves PM.

PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3297. doi: 10.1371/journal.pntd.0003297. eCollection 2014.

27.

Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.

Graves PM, Gelband H, Garner P.

Cochrane Database Syst Rev. 2014 Jun 30;(6):CD008152. doi: 10.1002/14651858.CD008152.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(2):CD008152.

28.

Malaria prevalence, anemia and baseline intervention coverage prior to mass net distributions in Abia and Plateau States, Nigeria.

Noland GS, Graves PM, Sallau A, Eigege A, Emukah E, Patterson AE, Ajiji J, Okorofor I, Oji OU, Umar M, Alphonsus K, Damen J, Ngondi J, Ozaki M, Cromwell E, Obiezu J, Eneiramo S, Okoro C, McClintic-Doyle R, Oresanya O, Miri E, Emerson PM, Richards FO Jr.

BMC Infect Dis. 2014 Mar 26;14:168. doi: 10.1186/1471-2334-14-168.

29.

Estimation of insecticide persistence, biological activity and mosquito resistance to PermaNet® 2 long-lasting insecticidal nets over three to 32 months of use in Ethiopia.

Anshebo GY, Graves PM, Smith SC, Wills AB, Damte M, Endeshaw T, Shargie EB, Gebre T, Mosher AW, Patterson AE, Emerson PM.

Malar J. 2014 Mar 6;13:80. doi: 10.1186/1475-2875-13-80.

30.

Risk factors for anemia in children under 6 years of age in Ethiopia: analysis of the data from the cross-sectional Malaria IndicatorSurvey, 2007.

Reithinger R, Ngondi JM, Graves PM, Hwang J, Getachew A, Jima D; Ethiopia Malaria Indicator Survey Working Group.

Trans R Soc Trop Med Hyg. 2013 Dec;107(12):769-76. doi: 10.1093/trstmh/trt096. Epub 2013 Nov 11.

PMID:
24218415
31.

Community-wide distribution of long-lasting insecticidal nets can halt transmission of lymphatic filariasis in southeastern Nigeria.

Richards FO, Emukah E, Graves PM, Nkwocha O, Nwankwo L, Rakers L, Mosher A, Patterson A, Ozaki M, Nwoke BE, Ukaga CN, Njoku C, Nwodu K, Obasi A, Miri ES.

Am J Trop Med Hyg. 2013 Sep;89(3):578-87. doi: 10.4269/ajtmh.12-0775. Epub 2013 Aug 12.

32.

Physical durability of PermaNet 2.0 long-lasting insecticidal nets over three to 32 months of use in Ethiopia.

Wills AB, Smith SC, Anshebo GY, Graves PM, Endeshaw T, Shargie EB, Damte M, Gebre T, Mosher AW, Patterson AE, Tesema YB, Richards FO Jr, Emerson PM.

Malar J. 2013 Jul 15;12:242. doi: 10.1186/1475-2875-12-242.

33.

Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011.

Graves PM, Makita L, Susapu M, Brady MA, Melrose W, Capuano C, Zhang Z, Dapeng L, Ozaki M, Reeve D, Ichimori K, Kazadi WM, Michna F, Bockarie MJ, Kelly-Hope LA.

Parasit Vectors. 2013 Jan 11;6:7. doi: 10.1186/1756-3305-6-7. Review.

34.

Analysis of malaria surveillance data in Ethiopia: what can be learned from the Integrated Disease Surveillance and Response System?

Jima D, Wondabeku M, Alemu A, Teferra A, Awel N, Deressa W, Adissie A, Tadesse Z, Gebre T, Mosher AW, Richards FO, Graves PM.

Malar J. 2012 Sep 17;11:330. doi: 10.1186/1475-2875-11-330.

35.

Primaquine for reducing Plasmodium falciparum transmission.

Graves PM, Gelband H, Garner P.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008152. doi: 10.1002/14651858.CD008152.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(6):CD008152.

PMID:
22972117
36.

Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers.

Bousema T, Dinglasan RR, Morlais I, Gouagna LC, van Warmerdam T, Awono-Ambene PH, Bonnet S, Diallo M, Coulibaly M, Tchuinkam T, Mulder B, Targett G, Drakeley C, Sutherland C, Robert V, Doumbo O, Touré Y, Graves PM, Roeffen W, Sauerwein R, Birkett A, Locke E, Morin M, Wu Y, Churcher TS.

PLoS One. 2012;7(8):e42821. doi: 10.1371/journal.pone.0042821. Epub 2012 Aug 22.

37.

Performance of local light microscopy and the ParaScreen Pan/Pf rapid diagnostic test to detect malaria in health centers in Northwest Ethiopia.

Endeshaw T, Graves PM, Ayele B, Mosher AW, Gebre T, Ayalew F, Genet A, Mesfin A, Shargie EB, Tadesse Z, Teferi T, Melak B, Richards FO, Emerson PM.

PLoS One. 2012;7(4):e33014. doi: 10.1371/journal.pone.0033014. Epub 2012 Apr 20.

38.

Factors associated with mosquito net use by individuals in households owning nets in Ethiopia.

Graves PM, Ngondi JM, Hwang J, Getachew A, Gebre T, Mosher AW, Patterson AE, Shargie EB, Tadesse Z, Wolkon A, Reithinger R, Emerson PM, Richards FO Jr.

Malar J. 2011 Dec 13;10:354. doi: 10.1186/1475-2875-10-354.

39.

Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic areas.

Shiferaw W, Kebede T, Graves PM, Golasa L, Gebre T, Mosher AW, Tadesse A, Sime H, Lambiyo T, Panicker KN, Richards FO, Hailu A.

Trans R Soc Trop Med Hyg. 2012 Feb;106(2):117-27. doi: 10.1016/j.trstmh.2011.10.006. Epub 2011 Dec 10.

PMID:
22154976
40.

Malaria, Oromia regional state, Ethiopia, 2001-2006.

Olana D, Chibsa S, Teshome D, Mekasha A, Graves PM, Reithinger R.

Emerg Infect Dis. 2011 Jul;17(7):1336-7. doi: 10.3201/eid1707.100942. No abstract available.

41.

Which nets are being used: factors associated with mosquito net use in Amhara, Oromia and Southern Nations, Nationalities and Peoples' Regions of Ethiopia.

Ngondi JM, Graves PM, Gebre T, Mosher AW, Shargie EB, Emerson PM, Richards FO Jr; Ethiopia Malaria Indicator Survey Working Group.

Malar J. 2011 Apr 17;10:92. doi: 10.1186/1475-2875-10-92.

42.

Oral vaccines for preventing cholera.

Sinclair D, Abba K, Zaman K, Qadri F, Graves PM.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD008603. doi: 10.1002/14651858.CD008603.pub2. Review.

43.

Rapid increase in ownership and use of long-lasting insecticidal nets and decrease in prevalence of malaria in three regional States of ethiopia (2006-2007).

Shargie EB, Ngondi J, Graves PM, Getachew A, Hwang J, Gebre T, Mosher AW, Ceccato P, Endeshaw T, Jima D, Tadesse Z, Tenaw E, Reithinger R, Emerson PM, Richards FO, Ghebreyesus TA.

J Trop Med. 2010;2010. pii: 750978. doi: 10.1155/2010/750978. Epub 2010 Sep 23.

44.

Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected).

Graves PM, Deeks JJ, Demicheli V, Jefferson T.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD000974. doi: 10.1002/14651858.CD000974.pub2. Review.

45.

Knowledge of malaria and its association with malaria-related behaviors--results from the Malaria Indicator Survey, Ethiopia, 2007.

Hwang J, Graves PM, Jima D, Reithinger R, Kachur SP; Ethiopia MIS Working Group.

PLoS One. 2010 Jul 21;5(7):e11692. doi: 10.1371/journal.pone.0011692.

46.

Comparison of Parascreen Pan/Pf, Paracheck Pf and light microscopy for detection of malaria among febrile patients, Northwest Ethiopia.

Endeshaw T, Graves PM, Shargie EB, Gebre T, Ayele B, Yohannes G, Zerihun M, Genet A, Melak B, Kebede A, Jima D, Tadesse Z, Ngondi J, Mosher AW, Richards FO, Emerson PM.

Trans R Soc Trop Med Hyg. 2010 Jul;104(7):467-74. doi: 10.1016/j.trstmh.2010.03.003. Epub 2010 Apr 7.

PMID:
20378137
47.

Malaria indicator survey 2007, Ethiopia: coverage and use of major malaria prevention and control interventions.

Jima D, Getachew A, Bilak H, Steketee RW, Emerson PM, Graves PM, Gebre T, Reithinger R, Hwang J; Ethiopia Malaria Indicator Survey Working Group.

Malar J. 2010 Feb 24;9:58. doi: 10.1186/1475-2875-9-58.

48.

Individual, household and environmental risk factors for malaria infection in Amhara, Oromia and SNNP regions of Ethiopia.

Graves PM, Richards FO, Ngondi J, Emerson PM, Shargie EB, Endeshaw T, Ceccato P, Ejigsemahu Y, Mosher AW, Hailemariam A, Zerihun M, Teferi T, Ayele B, Mesele A, Yohannes G, Tilahun A, Gebre T.

Trans R Soc Trop Med Hyg. 2009 Dec;103(12):1211-20. doi: 10.1016/j.trstmh.2008.11.016. Epub 2009 Jan 13.

PMID:
19144366
49.

Malaria prevalence and mosquito net coverage in Oromia and SNNPR regions of Ethiopia.

Shargie EB, Gebre T, Ngondi J, Graves PM, Mosher AW, Emerson PM, Ejigsemahu Y, Endeshaw T, Olana D, WeldeMeskel A, Teferra A, Tadesse Z, Tilahun A, Yohannes G, Richards FO Jr.

BMC Public Health. 2008 Sep 21;8:321. doi: 10.1186/1471-2458-8-321.

50.

Evaluation of light microscopy and rapid diagnostic test for the detection of malaria under operational field conditions: a household survey in Ethiopia.

Endeshaw T, Gebre T, Ngondi J, Graves PM, Shargie EB, Ejigsemahu Y, Ayele B, Yohannes G, Teferi T, Messele A, Zerihun M, Genet A, Mosher AW, Emerson PM, Richards FO.

Malar J. 2008 Jul 3;7:118. doi: 10.1186/1475-2875-7-118.

Supplemental Content

Loading ...
Support Center